A new blood test developed by researchers at the BC Cancer Agency and the Vancouver Prostate Centre is garnering international attention, and has the potential to improve the way a deadly form of prostate cancer, metastatic castration-resistant prostate cancer (CRPC), is treated.
The Coalition to Cure Prostate Cancer (CCPC) Special Challenge Award will fund the Prostate Cancer Extinction Research program under the leadership of Dr. Martin Gleave of the University of British Columbia and Vancouver Prostate Centre.
The 2014 Movember Team Grant has been awarded to Dr. John Bartlett of the Ontario Institute for Cancer Research. Dr. Ralph Buttyan of the Vancouver Prostate Centre is one of 14 co-Invesitagors on this award. Read the full story here.
Vancouver, BC – July 8, 2014 – British Columbia’s researchers are internationally renowned for their cutting-edge work in prostate cancer research, and their win streak continues with Prostate Cancer Canada’s (PCC) announcement of a new $450,000 research grant to Dr. Mads Daugaard, a senior research scientist with the Vancouver Prostate Centre.
Rocco Rossi from Prostate Cancer Canada visited the Vancouver Prostate Centre on June 6, 2014 to present the $50,000 raised by local PCC events: the Vancouver Wake Up Call Breakfast, Pants Off for Prostate Cancer and Do it for Dads Step Up Challenge.
Vancouver Prostate Centre scientists were the recipients of five of the twenty-six 2014 Movember Discovery Grants awarded by Prostate Cancer Canada on June 5, receiving three as principal investigators and two as co-investigators.
VICTORIA – The Province of BC is providing $1 million to VGH & UBC Hospital Foundation to support men’s health through the Prostate Cancer Supportive Care Program, which offers support to prostate cancer patients and their partners for physical and emotional side effects of the disease.
Four researchers from Vancouver Prostate Centre are recipients of Prostate Cancer Research Awards from the U.S. Department of Defense’s Congressionally Directed Medical Research Programs. The awards total more than $2.8 million US.
A groundbreaking discovery by researchers at The Vancouver Prostate Centre (VPC), a Vancouver Coastal Health Research Institute (VCHRI) centre, is giving scientists unprecedented levels of accuracy in seeing how patient-specific prostate (tumors) respond to drug therapies or develop drug resistance.
VANCOUVER – Today the Canadian Institutes of Health Research (CIHR) is announcing it will match funding from BRI Biopharmaceutical Research Inc (BRI) for a total of $750,000 over a three year Industry Partnered Collaborative Research Grant. This money will enable ongoing research collaborations between Dr. Yuzhuo Wang’s laboratories at the BC Cancer Agency and Vancouver Prostate Centre (VPC), and BRI to develop new state-of-the-art experimental cancer models.